Stockreport

Kura Oncology: Safety Profile Of Komzifti Supports My Upgrade To Strong Buy [Seeking Alpha]

Kura Oncology, Inc.  (KURA) 
Last kura oncology, inc. earnings: 2/25 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.kuraoncology.com/investor-relations
PDF Komzifti's FDA approval for relapsed/refractory NPM1-mutated AML is de-risked; the true equity upside lies in frontline AML expansion. Recent data show high remission [Read more]